Table 1.
Characteristics | Overall | CD80/86(+) | |||
No. | % | No. | % | ||
Age, years | |||||
Range | 38–83 | 38–78 | |||
Median | 50 | 46 | |||
Mean | 53 | 50 | |||
Sex | |||||
Male | 42 | 84 | 10 | 91 | |
Female | 8 | 16 | 1 | 9 | |
Pathology (WHO classification) | |||||
Type I | -- | -- | |||
Type II | 35 | 70 | 6 | 55 | |
Type III | 15 | 30 | 5 | 45 | |
T Stage (1997 AJCC) | |||||
T1 or T2 | 32 | 64 | 9 | 82 | |
T3 or T4 | 18 | 36 | 2 | 18 | |
N Stage (1997AJCC) | |||||
N0 or N1 | 24 | 48 | 6 | 55 | |
N2 | 17 | 34 | 3 | 27 | |
N3 | 9 | 18 | 2 | 18 | |
Overall Stage (1997 AJCC) | |||||
I | 5 | 10 | 3 | 27 | |
II | 10 | 20 | 3 | 27 | |
III | 13 | 26 | 2 | 18 | |
IV | 22 | 44 | 3 | 27 | |
Treatment | |||||
Radiotherapy alone | 8 | 16 | 2 | 18 | |
Concurrent Chemoradiotherapy | 42 | 84 | 9 | 82 | |
Status | |||||
Death | 16 | 32 | 0 | 0 | |
Alive | 34 | 68 | 11 | 100 |
Abbreviations: WHO, World Health Organization; AJCC, American Joint Committee on Cancer; FDRC, Follicular Dendritic Reticulum Cells